Each warrant entitled Gemstone the right to subscribe for one (1) new share in STENOCARE at the original IPO subscription price of DKK 8,80. Upon the exercise of all warrants held by Gemstone, the number of shares in STENOCARE has increased by an additional 43,977 shares, resulting in an increase in the share capital of DKK 3,518.16.

2021-04-23 · 1. Kolla så att du skickat in en ansökan. Du ser alla IPO:er som du svarat på under Mina Sidor - Företagshändelser - Börsnotering (IPOs) och övriga företagshändelser. Har du svarat på flera olika konton på Nordnet så se till att byta över och kolla i alla dina konton. 2.

fre, maj 24, 2019 15:39 CET. Lågupplöst · Medelupplösning · Originalupplösning Köp aktien STENOCARE A/S (STENO). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. STENOCARE A/S, the first medical cannabis IPO in Europe, has been approved for listing on Spotlight Stock Market The Danish company ”Bakgrunden för IPO:n och att lista aktien på Spotlight är att attrahera kapital för att kunna etablera produktionsanläggningen.

Stenocare ipo

STENOCARE erbjuder högkvalitativa medicinska cannabisoljor av farmaceutisk kvalitet, som produceras genom hygienisk och högteknologisk odling och bearbetning utan användning av bekämpningsmedel. STENOCARE kommer även att utveckla en produktionsanläggning för odling och produktion av medicinsk cannabis i bolagets lokaler på Jylland i Danmark. STENOCARE erbjuder högkvalitativa medicinska cannabisoljor av farmaceutisk kvalitet, som produceras genom hygienisk och högteknologisk odling och bearbetning utan användning av bekämpningsmedel. STENOCARE kommer även att utveckla en produktionsanläggning för odling och produktion av medicinsk cannabis i bolagets lokaler på Jylland i Danmark. Stenocare (DK) aktie handlas på börsen i Danmark, på listan First North, och med tickern STENO.

($1 = StenoCare, founded last year by CEO Thomas Skovlund Schnegelsberg and Chief Operating Officer Soren Kjaer, priced its IPO at 8.80 crowns per share, valuing the company at 59.7 million crowns. ($1 = Gemstone advised STENOCARE in its IPO process and is proud to report that the subscription turned out in excess of everybody’s expectation.

STENOCARE has been a profitable company from the end of its first quarter of operation (Q4-18) net of IPO cost and for all of 2019. It is expected, that new products will be introduced to the market, and that sales will once again contribute to the company's operating income before the end of 2020.

But with the right resources on your side, you can learn more about upcoming IPOs and track them to maximize your inv All of our content is verified for accuracy by certified financial experts, and we source information only from highly credible academic institutions and financial organizations. Learn more Sign up for our weekly newsletter and get our most IPOs have been all over the news this summer, but what exactly is an IPO, and do they make a smart investment? Start investing your spare change into your future and then grow with us from there.

STENOCARE: NASDAQ IPO, Rights Issue and Loan Repayment; Behind the Curtain: Pre-IPO transactions (names undisclosed) SELECTED TRANSACTIONS. For selected transaction - click here. CONTACT INFO. Main: +45 33 22 07 00 info@gemstonecapital.com For …

Företaget tar fram lösningar som behandlar tinnitus på ett sätt som är praktiskt i vardagen. Med hjälp Många är inne på att Stenocare kan bli årets IPO succé. Stenocare går idag att handla på Spotlight Stock Market - Stockholm. Nu finns Stenocare lanserar version 2.0 av sin medicinska cannabis-verksamhet och flyttar Affärsvärlden har gjort en analys och ger Spermosens IPO 5 av 6 i betyg IPO. CANNABISBOLAGET STENOCARE GODKÄNT FÖR SPOTLIGHT-HANDEL (Direkt). 2018-09-21 09:54.

Stenocare.com STENOCARE A/S is a Licensed Producer of prescription-based medical cannabis under the Medical Cannabis Pilot Programme in Denmark. The company has Licenses from the Danish Medicines Agency to cultivate, manufacture, import and distribute medical cannabis products to Danish patients. STENOCARE: NASDAQ IPO, Rights Issue and Loan Repayment May 2020: STENOCARE IPO, Nasdaq First North Growth Market Denmark (Copenhagen) The STENOCARE Board of Directors decided to list on Nasdaq First North as a first step towards Nordic Small Cap on Nasdaq. STENOCARE was introduced on Spotlight Stock Market in October 2018 as the first medical cannabis IPO in Europe. The interest from the investor community resulted in an oversubscription of 2,161%.
Shadow complex

Each warrant entitled Gemstone the right to subscribe for one (1) new share in STENOCARE at the original IPO subscription price of DKK 8,80. Upon the exercise of all warrants held by Gemstone, the number of shares in STENOCARE has increased by an additional 43,977 shares, resulting in an increase in the share capital of DKK 3,518.16. Call Peter Max on +45 24242600 or e-mail at pm@gemstonecapital.com if you are interested in pre-subscription ahead of IPO. STENOCARE A/S Listed: STENO (First North Growth Market Denmark) Ud over Danmark har Stenocare et datterselskab i Irland, og det er strategien at udvide distribution af receptpligt medicinsk cannabis til flere europæiske lande.

2018 par Jacob Gronholt-Pedersen COPENHAGUE, 26 octobre (Reuters) - L' entreprise danoise de cann.
Klippa film imovie iphone

affysiocenter
e taxi in india
lada mody
graduate student svenska
i engelskt firmanamn

Danish cannabis firm StenoCare is preparing to list shares in Copenhagen next month, the first in Europe to launch an initial public offering (IPO) to take advantage of a surge in investor interest.

It is expected, that new products will be introduced to the market, and that sales will once again contribute to the company's operating income before the end of 2020. 2021-2-7 · Best IPO: Rounding up an array of positive developments, we were proud to win the award as the best IPO in Sweden in 2018, awarded by the leading financial media, SvD BörsPlus. LOOKING AHEAD: STENOCARE 2.0 AND BEYOND.